Author

T. J. Kottom

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

A. H. Limper· 2 shared C. Braun· 1 shared E. M. Carmona· 1 shared J. Chae· 1 shared M. Girtman· 1 shared M. H. Bourne· 1 shared P. Jenson· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. H. Limper

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Gene Expression in Lung Epithelial Cells Following Interaction with Pneumocystis carinii and its Specific Life Forms Yields Insights into Host Gene Responses to Infection

T. J. Kottom, E. M. Carmona, A. H. Limper

The paper examines gene expression changes in lung epithelial cells after interaction with Pneumocystis carinii life forms, identifying cytokine, apoptotic, and anti-apoptotic gene responses.

bioRxiv · Nov 22, 2021Microbiology

Inhibition of fibrosis with multi-agent therapy in pulmonary fibrosis: Results of a drug library screening

C. Braun, M. Girtman, P. Jenson, M. H. Bourne, J. Chae, T. J. Kottom, A. H. Limper

This study screens FDA-approved drugs to identify synergistic combinations for treating pulmonary fibrosis, finding that azole antifungals may enhance anti-fibrotic effects when combined with existing therapies.

bioRxiv · Jun 29, 2020 · PreprintCell Biology